Automated perimetry visual fields (VFs) are core data for glaucoma diagnosis and monitoring but may also contain vertical-meridian-respecting deficits that reflect neurologic disease such as stroke, hemorrhage, or neoplasm. Standard glaucoma AI pipelines typically are not audited for such neurological field patterns. The authors developed CHIASM, a self-supervised VF encoder, to learn anatomically meaningful VF structure from unlabeled perimetry and to evaluate whether that representation can identify suspected neurologic patterns in independent glaucoma datasets.
CHIASM is a masked autoencoder with a 128-dimensional latent space. The model was pretrained on monocular pattern-deviation inputs from Humphrey automated perimetry. Pretraining used 23,223 unlabeled VFs drawn from a patient-grouped training split that in total included 28,943 fields from 3,871 patients in the UWHVF (all-comers perimetry) dataset.
The objective during pretraining was masked reconstruction of the input field; this allowed the model to learn recurring spatial structure without labels. A comparator total-deviation encoder was also analyzed for contrast with CHIASM's masked-reconstruction latent specialization.
After pretraining, a supervised linear classifier was trained using only the vertical-midline latent dimensions from CHIASM. The classifier used per-eye expert labels indicating neurological versus non-neurological VF patterns. Performance was assessed with hard-negative cross-validation. Specificity was further evaluated on 100 held-out UWHVF controls that were structurally separated from training data.
Cross-validated performance reported for the classifier included a balanced accuracy of 0.78 (95% CI, 0.75–0.82) and area under the receiver operating characteristic curve (AUC) of 0.85 (95% CI, 0.82–0.89). The held-out control set produced no false positives under the reported evaluation.
To test generalization, the classifier was applied without any fine-tuning to the Harvard-Glaucoma Fairness dataset (Harvard-GF), which contains 3,300 patients with paired VF and optical coherence tomography (OCT) from a single academic center. Harvard-GF was not used at any stage of model development or pretraining.
When applied to Harvard-GF glaucoma-labeled patients, the model produced a ranked set of cases based on morphology inconsistent with typical glaucomatous field loss. The top-20 flagged cases came from 1,748 glaucoma-labeled patients and represented 1.1% of that subgroup.
Masked reconstruction produced latent dimensions that aligned with retinal neuroanatomy. Specifically, 50 of 128 latent dimensions in CHIASM showed spatial specialization, compared with 23 specialized dimensions in the total-deviation encoder. This indicates a stronger emergence of anatomically interpretable structure from masked reconstruction training.
Classifier performance on internal cross-validation showed balanced accuracy 0.78 (95% CI, 0.75–0.82) and AUC 0.85 (95% CI, 0.82–0.89). No false positives were observed among the 100 held-out UWHVF controls used to assess specificity.
On Harvard-GF, the top-20 flagged glaucoma-labeled patients were consistent with neurologic hemifield patterns by multiple corroborative measures. All 20 were positive on a rule-based Neurological Hemifield Test (mean score 62.4). In OCT comparisons with severity-matched controls, the flagged patients showed preserved superior retinal nerve fiber layer (Cohen d = +0.68; P < .001) and preserved inferior retinal nerve fiber layer (Cohen d = +0.63; P = .003), findings that are inconsistent with typical glaucomatous RNFL thinning and support a suspected non-glaucomatous etiology for the VF morphology.
A self-supervised VF encoder trained without labels learned anatomically interpretable structure and enabled a classifier to identify suspected neurologic visual field patterns in a curated glaucoma dataset. The authors suggest that VF datasets used to train glaucoma AI systems may benefit from neurological screening before model training to avoid confounding and to improve safety and generalizability.
CHIASM is presented as a tool to support such audits and as a foundation for neuro-ophthalmic AI applications that extend beyond the more commonly used imaging modalities such as fundus photography and OCT.
The source reports competing interests (including a provisional patent application related to visual field analysis by one author and other disclosures) and confirms ethical approvals and patient consent statements for the UWHVF and Harvard-GF datasets. The report does not provide additional unreported limitations beyond what appears in the source; any further methodological details or broader external validations beyond those cited were not reported in the source article.
Data and code for the UWHVF and Harvard-GF datasets are available at the repositories listed in the source: https://github.com/uw-biomedical-ml/uwhvf and https://github.com/Harvard-Ophthalmology-AI-Lab/Harvard-GF. The authors declare relevant competing interests as described in the source and confirm that institutional review and participant consent procedures were followed for the datasets used.